H-CYTE (OTCMKTS:HCYTD) Shares Down 49.5% – Here’s Why

H-CYTE, Inc. (OTCMKTS:HCYTD)’s share price traded down 49.5% during trading on Friday . The stock traded as low as $2.02 and last traded at $2.02. 400 shares traded hands during trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00.

H-CYTE Trading Down 49.5 %

The firm’s 50-day simple moving average is $2.02 and its 200 day simple moving average is $2.02.

H-CYTE Company Profile

H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.